USA – FDA updates Q-Sub guidance ahead of new Pre-Sub draft guidance

The US Food and Drug Administration has updated its final guidance on its Q-Submission program in line with changes negotiated in the recent medical...
Statement on the Investigational Use of Marketed Drugs in Clinical Trials

Canada – Proposed changes to the Medical Devices Regulations to address future public health...

Health Canada is proposing regulatory amendments to the Medical Devices Regulations (MDR). We're proposing to expand the current provisions under Part 1.1 of the MDR, currently...

USA – AdvaMed calls for changes to FDA’s non-spinal bone fixation device guidance

The medtech lobby group AdvaMed has asked the US Food and Drug Administration (FDA) to make changes to its recent guidance on orthopedic non-spinal...

USA – FDA finalizes guidance for containment system used with power morcellators

The US Food and Drug Administration (FDA) has finalized guidance that lists non-clinical testing information the agency wants from sponsors of tissue containment systems...

Europe – MedTech Europe’s vision for a resilient medical technology ecosystem

The digital ecosystem has dramatically changed the way in which healthcare is delivered to patients. Nowadays, medical technology companies concentrate not only on ensuring...

Australia – Phase out of ISO 13485 certificates for IVD medical devices

The transition period for the TGA to accept ISO 13485 certificates as manufacturer evidence for in vitro diagnostic (IVD) medical devices ends on 26...
MDCG 2020-3 Guidance on significant changes regarding the transitional provision under Article 120 of the MDR with regard to devices covered by certificates according to MDD or AIMDD

Europe – Euro Convergence: Experts call for more IVD-specific guidance during IVDR transition

Notified body representatives say that when regulators develop guidance for the In Vitro Diagnostics Regulation (IVDR) they need to get more input from IVD...
SCCS - Final Opinion on Solubility of Synthetic Amorphous Silica (SAS)

Europe – UPDATE – MDCG 2020-3 Rev.1 – Guidance on significant changes regarding the...

Article 120(3) of the Medical Device Regulation (EU) 2017/745 (MDR), last amended by Regulation (EU) 2023/607, states that devices which continue to comply with...

Europe – GUIDANCE on the content and structure of the summary of the...

This document is intended to provide Commission guidance, in accordance with Article 77(6) of Regulation (EU) 2017/745 of the European Parliament and of the Council of...

USA – MedCon: Consider the device risk management file a ‘living document’

Device manufacturers need to keep their risk documentation up to date throughout the total product life cycle by monitoring production and post-production information, according...

NOS PROCHAINES FORMATIONS